Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review
Nadine S. van den Ende, Anh H. Nguyen, Agnes Jager, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2969-2969
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
Laura M. Spring, Sara M. Tolaney, Geoffrey Fell, et al.
Annals of Oncology (2023) Vol. 35, Iss. 3, pp. 293-301
Open Access | Times Cited: 33
Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis
Francisco Cézar Aquino de Moraes, Maria Eduarda Cavalcanti Souza, Vitor Kendi Tsuchiya Sano, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 7
Development and validation of a nomogram to predict survival after neoadjuvant chemotherapy in elderly women with triple-negative invasive ductal breast cancer
Ying Gao, Jinmiao Wang, Shoujun Wang, et al.
Saudi Medical Journal (2025) Vol. 46, Iss. 1, pp. 43-51
Open Access
The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based study
Jenny Nyqvist, Mostafa Helou, Khalil Helou, et al.
Breast Cancer Research and Treatment (2025)
Open Access
Triple-Negative Breast Cancer: Radiologic-Pathologic Correlation
Amrita Valluri, Gloria J Carter, Inna Robrahn, et al.
Journal of Breast Imaging (2025)
Closed Access
Evaluation of Anticancer Activity of Novel and Tumor-Targeted Glutamine-Conjugated Organotin(IV) Compounds in Colorectal Cancer─An In Vitro and In Vivo Study
Shagun Sharma, Varinder Kaur, Pratibha Duhan, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Mechanistic insights into pachymic acid’s action on triple-negative breast Cancer through TOP2A targeting
Ming Liu, Li Zheng, Yang Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Intrinsic Subtype and Immunity Score in identification of Triple-Negative Breast Cancer at Low Risk
Xinyu Ren, Tong Zhou, Yu Song, et al.
The Breast (2025), pp. 103889-103889
Open Access
Classifications of triple-negative breast cancer: insights and current therapeutic approaches
Ziqi Chen, Yumeng Liu, Mingzhi Lyu, et al.
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Implantable Polymer Scaffolds Loaded with Paclitaxel–Cyclodextrin Complexes for Post-Breast Cancer Tissue Reconstruction
Liliana-Roxana Balahura, Andreea I. Dinu, Adriana Lungu, et al.
Polymers (2025) Vol. 17, Iss. 3, pp. 402-402
Open Access
The value of inflammation-related indicators in chemotherapy efficacy and disease-free survival of triple-negative breast cancer
Jie Zhu, Jiale Cheng, Yuyuan Ma, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Trends and Technology Development in Life Science
С. Прохоров Е
(2023)
Open Access | Times Cited: 15
Immunotherapy: breakthrough in Cancer Treatment
Reshmi Gopalakrishnan, B Thamaraiselvi
(2023), pp. 171-177
Open Access | Times Cited: 15
Genetically Modified Organisms (GMOs): Balancing Benefits and Ethical Considerations
Deepa VH, Prakriti Pushp
(2023), pp. 178-190
Open Access | Times Cited: 15
Curcumin suppresses metastasis of triple-negative breast cancer cells by modulating EMT signaling pathways: An integrated study of bioinformatics analysis
Ze Chen, Pinjun Lu, Menghan Li, et al.
Medicine (2024) Vol. 103, Iss. 8, pp. e37264-e37264
Open Access | Times Cited: 5
Single‐cell transcriptome sequencing reveals SPP1‐CD44‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC
Fuzhong Liu, Junfeng Zhang, Xiaowei Gu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 13
Open Access | Times Cited: 4
Precision Agriculture
Kavitha. S. Raj
(2023), pp. 55-71
Open Access | Times Cited: 13
Triple-negative breast cancer: from none to multiple therapeutic targets in two decades
Filomena Marino Carvalho
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy
Yuan Ma, Huarui Zhang, Xinyang Shen, et al.
Cancer Letters (2024) Vol. 598, pp. 217102-217102
Open Access | Times Cited: 4
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial
Nour Abuhadra, Ryan Sun, Clinton Yam, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3275-3275
Open Access | Times Cited: 8
Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast Cancer
Emina Torlakovic, Nick Baniak, Penny J. Barnes, et al.
Laboratory Investigation (2024) Vol. 104, Iss. 7, pp. 102076-102076
Open Access | Times Cited: 2
Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy
Zhendong Shi, Yingxue Liu, Xuan Fang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review
Maryam Golmohammadi, Mohammad Yasin Zamanian, Ahmed Muzahem Al‐Ani, et al.
Animal Models and Experimental Medicine (2024)
Open Access | Times Cited: 2
SP1-Induced Upregulation of LncRNA AFAP1-AS1 Promotes Tumor Progression in Triple-Negative Breast Cancer by Regulating mTOR Pathway
Fangyuan Li, Daheng Xian, Junying Huang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13401-13401
Open Access | Times Cited: 5
Upregulation of CENPM promotes breast carcinogenesis by altering immune infiltration
Yanchu Tong, Tongzhou Zhou, Xiaokun Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top